CFTR and cystic fibrosis: In vitro validation of a CRISPR/Cas9-mediated gene correction strategy for cystic fibrosis has been performed in pig cells, which demonstrated the precise integration and persistent functional expression of the human cystic fibrosis transmembrane conductance regulator (CFTR) gene.